10-Q: i3 Verticals Reports Q2 2025 Results: Revenue Up, Strategic Divestitures Reshape Company Focus

i3 Verticals announces its Q2 2025 results, showcasing revenue growth alongside strategic divestitures aimed at sharpening the company's focus on software solutions.

Summary

• i3 Verticals, Inc. reported its financial results for the quarter ended March 31, 2025.
• Revenue increased by 8.8% to $63.1 million compared to $58.0 million in the same period last year.
• The company completed the sale of its Healthcare RCM Business on May 5, 2025, for $96.0 million in cash.
• The sale of the Merchant Services Business was completed on September 20, 2024, for approximately $437 million.
• The company's core business is now focused on delivering software solutions integrated with its payment facilitator platform.
• The company has two reportable segments: Public Sector and Healthcare.
• ARR from continuing operations for the three months ended March 31, 2025 was $199.1 million, a 7% increase year-over-year.
• The company repurchased 510,155 shares of Class A Common Stock under the Share Repurchase Program at an average price of $22.51 per share for a total cost of $11.6 million.
• The company is involved in ordinary course legal proceedings, including the S&S Litigation, but does not believe these matters will have a material impact on the company's consolidated balance sheet, results of operations or cash flows.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While revenue and ARR are up, net income is down, and there are risks associated with the strategic shift. The company is performing well but has challenges to address.

Positives

• Revenue increased by 8.8% to $63.1 million.
• ARR from continuing operations grew by 7% to $199.1 million.
• The company successfully divested its Healthcare RCM Business for $96.0 million.
• The company repurchased 510,155 shares of Class A Common Stock, indicating confidence in its value.
• The company maintains a strong liquidity position with $7.7 million in cash and $438.0 million available under its credit facility.
• The company is in compliance with its debt covenants, with a consolidated interest coverage ratio of 92.5x and a total leverage ratio of 0.1x.

Negatives

• Net income decreased by 20.6% to $3.877 million.
• Net cash used in operating activities was $15.6 million, a decrease of $40.8 million compared to the prior year.
• The company is involved in the S&S Litigation, which could potentially impact results of operations or cash flows.
• The company's effective tax rate was 74% for the three months ended March 31, 2025, which is significantly higher than the federal statutory rate of 21%.

Risks

• Rapidly evolving domestic and global conditions could materially adversely affect the business.
• The company is now highly dependent on the success of its remaining Public Sector business.
• There are certain risks associated with the sale of the Healthcare RCM Business.
• The company is involved in the S&S Litigation, which could potentially impact results of operations or cash flows.
• The company's future consolidated financial results will not be comparable to prior periodic reports due to the sale of the Healthcare RCM Business.

Future Outlook

The company expects that its cash flow from operations, current cash and cash equivalents, and available borrowing capacity under the 2023 Senior Secured Credit Facility will be sufficient to fund its cash needs for at least the next twelve months and foreseeable future.

Industry Context

The company's strategic shift towards software solutions aligns with the increasing demand for digital transformation and automation in both the public and private sectors. The divestitures of the Merchant Services and Healthcare RCM businesses reflect a focus on higher-margin, recurring revenue streams.

Comparison to Industry Standards

• It is difficult to compare i3 Verticals directly to industry standards without knowing the specific sub-sectors within public sector and healthcare software in which they primarily compete.
• However, companies like Tyler Technologies (TYL) in the public sector and Cerner (now Oracle Health) or Veeva Systems (VEEV) in healthcare are benchmarks for software and technology solutions.
• Comparing i3 Verticals' ARR growth and EBITDA margins to these larger players would provide a better sense of their relative performance.
• For example, Veeva Systems, which focuses on cloud-based software for the life sciences industry, often boasts high recurring revenue and strong EBITDA margins, serving as a benchmark for software companies.
• Similarly, Tyler Technologies, a major player in public sector software, is known for its stable revenue and profitability.
• i3 Verticals' ability to maintain or exceed industry average growth rates and profitability metrics would be a positive indicator.

Legal Proceedings

• The company is involved in ordinary course legal proceedings, including the S&S Litigation, but does not believe these matters will have a material impact on the company's consolidated balance sheet, results of operations or cash flows.

Related Party Transactions

• The company is party to a Tax Receivable Agreement with i3 Verticals, LLC and the Continuing Equity Owners, which provides for the payment by the company to the Continuing Equity Owners of 85% of the amount of certain tax benefits.

Stakeholder Impact

• Shareholders: The share repurchase program and strategic focus on software solutions could positively impact shareholder value.
• Employees: The sale of the Healthcare RCM Business may impact employees in that division.
• Customers: The focus on software solutions aims to provide more efficient and responsive services.
• Creditors: The company remains in compliance with its debt covenants, indicating financial stability.

Next Steps

• Continue to execute on the company's strategy of delivering software solutions in strategic vertical markets.
• Focus on integrating recent acquisitions and driving organic growth.
• Manage the transition following the sale of the Healthcare RCM Business.
• Monitor and mitigate risks related to economic and geopolitical conditions.
• Continue to evaluate and execute on share repurchase program.

Key Dates

Keywords

revenue, i3 Verticals, financial results, ARR, Healthcare RCM Business, Public Sector, divestiture, share repurchase, credit facility, acquisitions